AbGeneron’s main scope is the research and development of novel antibody diagnostics and biopharmaceuticals (mAbs).
Our aim is to discover, optimise and produce novel and biosimilar antibody and protein medicines and diagnostics, combining recombinant DNA technology, structure based design with the use of AI and protein engineering methods.
We specialize in the development of next-generation biologics by integrating cutting-edge science with advanced engineering approaches.
Our bioprocessing division specializes in the production of high-quality antibody and protein therapeutics (biosimilars).
The are two main product target groups within the company’s research, manufacturing and commercial scope.